rs727504060
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_130837.3(OPA1):c.1352T>A(p.Leu451His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L451P) has been classified as Pathogenic.
Frequency
Consequence
NM_130837.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Leu396His (CTT>CAT): c.1187 T>A in exon 12 of the OPA1 gene (NM_015560.2) The L396H missense change was identified in the OPA1 gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. However, other missense mutations at the same position (L396R, L396P) have been reported previously in association with hereditary optic atrophy (Thiselton et al., 2002; Ferre et al., 2009). Furthermore, Leucine 396 is a highly conserved residue in the OPA1 protein that is close to a GTP-binding motif in the dynamin-related domain (Thiselton et al., 2002). Therefore, we interpret L396H to be a disease-associated mutation. The variant is found in OAPEO-MITOP panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at